UI
UNHCR Innovation

UNHCR Innovation Accelerator

Offers catalytic seed funding up to USD 250,000 to scale proven innovations for displaced people.

Between cyclesUNHCR InnovationGlobal

Expressions of interest go through a two-step screening — an eligibility screening and a minimum-standards review — before the Secretariat groups promising submissions into thematic clusters, where applicants build full proposals and strengthen partnerships with each other. A consortium isn't required to submit an expression of interest; a single organisation can apply alone, and any needed partne

The Accelerator backs organizations — UNHCR teams, refugee-led organizations, UN agencies, NGOs, academia and private-sector partners — with a tested, proven-concept solution that improves protection, inclusion or assistance for forcibly displaced and stateless people. It looks for innovations ready to move from pilot to sustainable, system-level scale, not concept-only ideas.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see where teams trip up

Guides for this application

All guides →
Gates Foundation logo
Open

Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows

Gates Foundation · United States

Funds research teams building low-cost, simplified pathogen-sequencing workflows that bring the cost of sequencing a sample down to about US$1-10 for use in low- and middle-income countries.

Biotech
$300K – $800KSep'26
GF
Open

Innovations in Low-Cost and Simplified Pathogen Sequencing Workflows

Gates Foundation · Global / Multinational

Funds teams up to $800,000 to build cheap pathogen-sequencing workflows for poorer countries.

Biotech
$800KSep'26
National Institutes of Health logo
Open

In Vivo High-Resolution Imaging for Inner Ear Visualization

NIH · United States

Funds building the imaging that can finally show hair cells and membranes inside a living human ear. A clinical trial is optional.

MedtechPhotonics+1
$500KOct'26
National Institutes of Health logo
Open

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification

NIH · United States

Funds building the assays and running the screens that find drug candidates for neurological disease — the on-ramp to NIH's Blueprint network.

BiotechNeurotech
$750KOct'27
FDA — Food and Drug Administration logo
Open

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases

FDA · United States

Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.

Biotech
$600KFeb'28
National Institutes of Health logo
Open

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery

NIH · United States

Funds building animal and tissue models that behave enough like a real neurological disease to test drugs against.

BiotechNeurotech
$750KOct'27